To find out, Osminds Chief Medical Officer, Will Sauv, MD, sat down with Brittany Albright, MD, Founder of Sweetgrass Psychiatry and Osmind Medical Advisor for the latest episode of Psychiatry Tomorrow
They make clinical sense when managing documented metabolic adaptation, addressing specific complaints of profound fatigue on GLP-1s, or when gastrointestinal side effects prevent the use of standard therapies
IV therapy is significantly more effective, providing 90-100% bioavailability compared to only 10-50% for oral supplements
The kicker is it was funded and authored by the exact same company selling the procedure
With the most advanced skin treatments in San Diego and industry-leading research, patients can achieve the best possible outcome